Core Viewpoint - Guangxi Tianyuan Biochemical Co., Ltd. is undergoing a listing review on the Shenzhen Stock Exchange, aiming to raise 629.75 million yuan, and is recognized as a leading enterprise in the pesticide formulation industry with significant technological achievements [1]. Company Overview - The company specializes in the research, production, and sales of pesticide formulations, gradually becoming a leading domestic enterprise in this sector and one of the few with the capability to industrialize innovative pesticides [1]. - It has received two National Science and Technology Progress Awards, highlighting its commitment to innovation in non-patented, created, and high-efficiency pesticide formulations [1]. Financial Performance - The company's operating revenues for the reporting periods were 1.712 billion yuan, 1.774 billion yuan, and 1.750 billion yuan, indicating stable business performance [2]. - Net profits for the same periods were 162 million yuan, 229 million yuan, and 249 million yuan, reflecting a solid profit level [2]. Key Financial Metrics - Total assets as of December 31, 2024, are projected to be 1.618 billion yuan, up from 1.364 billion yuan in 2023 and 1.355 billion yuan in 2022 [3]. - The equity attributable to shareholders is expected to reach 960 million yuan in 2024, compared to 784 million yuan in 2023 and 697 million yuan in 2022 [3]. - The asset-liability ratio is projected to decrease to 44.59% in 2024 from 51.19% in 2023 and 63.18% in 2022, indicating improved financial stability [3]. Profitability and Efficiency - Projected net profit for 2024 is 248.36 million yuan, an increase from 228.35 million yuan in 2023 and 161.89 million yuan in 2022 [4]. - The basic earnings per share are expected to be 2.37 yuan in 2024, up from 2.18 yuan in 2023 and 1.39 yuan in 2022 [4]. - Research and development expenditure is projected to account for 4.24% of operating revenue in 2024, compared to 2.71% in 2023 and 2.53% in 2022, indicating a growing focus on innovation [4].

证券代码：002588 证券简称：史丹利 公告编号：2025-021 史丹利农业集团股份有限公司 本公司及董事会全体成员保证公告的内容真实、准确、完整，没有虚假记载、误导 性陈述或重大遗漏。 一、对外担保概述 史丹利农业集团股份有限公司（以下简称"公司"或"保证人"）分别于 2025 年 4 月 17 日和 2025 年 5 月 13 日召开的第六届董事会第十三次会议、2024 年 度股东大会审议通过了《关于公司 2025 年度对外担保额度预计的议案》，同意 公司 2025 年度预计向对最近一期资产负债率未超过 70%的控股子公司松滋史丹 利宜化新材料科技有限公司（以下简称"松滋新材料"）提供担保额度预计不超 过人民币 4.60 亿元，松滋新材料其他股东按出资比例对其提供同等担保，松滋 新材料对该担保提供反担保。上述担保额度在任一时点的担保余额不得超过股 东大会审议通过的担保额度，担保方式为连带责任保证担保，担保额度有效期 自股东大会审议通过之日起 12 个月内有效。详细内容请见公司于 2025 年 4 月 《证券日报》和巨潮资讯网（www.cninfo.com.cn）的《关于公司 2025 年度对 外担保额 ...

Core Viewpoint - The pesticide industry, crucial for food security, is under scrutiny as Tianyuan Biochemical Co., Ltd. initiates its IPO process amidst a challenging market environment marked by stagnant revenue growth and high reliance on distributors [1][3]. Financial Performance - Tianyuan Biochemical's revenue from 2022 to 2024 shows minimal growth, with figures of 1.71 billion, 1.77 billion, and 1.75 billion yuan respectively, while net profits increased from 161.63 million to 248.55 million yuan [3][4]. - The company's total assets grew from 1.35 billion yuan in 2022 to 1.62 billion yuan in 2024, with a notable decrease in asset-liability ratio from 63.18% to 44.59% [4]. - The sales revenue from distributors accounted for over 96% of total revenue during the same period, indicating a heavy dependence on this sales model [4][5]. Market Dynamics - The pesticide market is characterized by intense competition and product homogenization, leading to declining sales prices, particularly for herbicides, which fell by 18.26% from 2023 to 2024 [6][7]. - The average gross margin of Tianyuan Biochemical is lower than that of comparable companies, with a gross margin of 36.07% in 2024 compared to an industry average of 36.22% [8]. R&D and Innovation - The company has consistently invested less in R&D compared to industry peers, with R&D expense ratios of 2.53%, 2.71%, and 4.24% from 2022 to 2024, which is below the industry average [9][10]. - There is a significant gap between R&D expenses and sales expenses, with R&D costs amounting to 74.26 million yuan in 2024 compared to over 226 million yuan in sales expenses [10][11]. Regulatory and Legal Issues - Tianyuan Biochemical has faced legal challenges and administrative penalties, including fines for selling unregistered pesticide products, which raises concerns about internal governance and compliance [13][14]. - The company has unresolved property rights issues, with 11,432.79 square meters of real estate lacking proper documentation, posing risks of administrative penalties [14][15]. Investor Sentiment - Recent cash dividends totaling 221 million yuan have raised concerns among investors about the company's financial management, particularly in light of its IPO fundraising of approximately 630 million yuan [16].

Group 1 - The article reports that Shunyi Co., Ltd. has been penalized by the Yangshan Customs for violating customs regulations, specifically for exporting pesticides without the required documentation [1][2] - The company declared two shipments of 20% Pesticide A and 20% Pesticide B, each weighing 7160.4 kg, with a total declared value of FOB $62,730 [1] - The actual goods exported were found to be 480g/L of Pesticide B, which required a specific export permit that was not submitted [1] Group 2 - The penalty imposed on Shunyi Co., Ltd. is a fine of RMB 89,000 [2] - Shunyi Co., Ltd. was established in December 1998 and has a registered capital of RMB 28.906 million, with total assets amounting to RMB 2.9 billion [2] - The company specializes in the production and sale of over 50 varieties of agricultural chemicals, including pesticides and pharmaceutical intermediates, and holds several domestic patents [2]

Investment Rating - The report maintains an "Outperform" rating for the agricultural chemical industry [7][10]. Core Views - The agricultural chemical industry is expected to benefit from rising prices of potassium fertilizer and glyphosate, with supply constraints for the insecticide "Kangkuan" [2][5]. - The potassium fertilizer market is characterized by tight supply and demand, with a significant reliance on imports, which is projected to increase due to food security concerns [2][27]. - The phosphoric chemical sector is anticipated to maintain high price levels due to the scarcity of phosphate rock resources and increasing demand from new applications [3][51]. Summary by Sections Potassium Fertilizer - Global potassium fertilizer prices are expected to recover as demand increases, with China being the largest consumer and heavily reliant on imports [2][27]. - Domestic production of potassium chloride is projected to decrease slightly in 2024, while imports are expected to reach a historical high [27]. - The domestic potassium chloride price is forecasted to rise by approximately 100 yuan/ton in July due to increased port prices [2][45]. Phosphoric Chemicals - The price of phosphate rock is expected to remain high due to declining grades and increasing extraction costs, with a tight supply-demand balance [3][51]. - As of June 30, 2025, the market price for 30% grade phosphate rock in Hubei is 1,040 yuan/ton, while in Yunnan it is 970 yuan/ton, both stable compared to the previous month [3][51]. - The export policy for phosphoric fertilizers emphasizes domestic priority, with reduced export quotas expected to alleviate downward pressure in the domestic market [4]. Pesticides - The supply of "Kangkuan" has been unexpectedly restricted, leading to a potential price increase for the product [5]. - Glyphosate prices have risen by 1,300 yuan/ton in June, driven by increased demand from South America as planting areas for soybeans and corn expand [5][9]. - The report recommends focusing on leading companies in the glyphosate sector, such as "Xingfa Group," which has a significant production capacity [9]. Key Company Recommendations - The report recommends "Yaji International" for potassium fertilizer, projecting production of 2.8 million tons in 2025 and 4 million tons in 2026 [5][49]. - For phosphoric chemicals, "Yuntianhua" and "Xingfa Group" are highlighted as key players due to their rich phosphate reserves [6]. - In the pesticide sector, "Xingfa Group" is recommended for its leading position in glyphosate production [9].

证券研究报告 | 行业周报 gszqdatemark 2025 07 06 年 月 日 基础化工 周观点："反内卷"有望带来细分板块景气修复 石化：伊以停火，油价回落。在伊以冲突加剧时，原本在 60-70 美元/桶区 间徘徊的布伦特原油价格一度冲高，最高时达到 78.85 美元/桶。随着以伊 局势的缓解，油价重回 60-70 美元/桶区间，截止 7 月 4 日，布伦特原油 收于 68.30 美元/桶，与本次冲突爆发前价格相比（6 月 12 日为 69.36 美 元/桶），地缘溢价已基本回吐。 原油重回基本面定价。根据最新预测，IEA、OPEC、EIA 在 6 月报中分别 预计 2025 年全球原油需求增量为 72、130、79 万桶/天，而全球供给增量 分别为 180、90、155 万桶/天，即在 IEA、EIA 的统计口径中，最新的原 油供求敞口分别达到+108、+76 万桶/天。而在基本面偏弱的背景下， OPEC+增产幅度仍屡超预期，继 5 月 41.1 万桶/天的超预期增产后（（比原 计划高出 27.3 万桶/天），5 月 31 日，OPEC 再度宣布将在 7 月实施 41.1 万桶/天的增产计划，增产 ...

Group 1 - The pesticide sector has experienced a significant surge, with companies such as Xinong Co., Ltd. (002942) and Suli Co., Ltd. (603585) hitting the daily limit up [1] - Beisi Mei (300796) has seen an increase of over 4%, indicating strong market interest [1] - Other companies like Xianda Co., Ltd. (603086), Xin'an Chemical (600596), and Lier Chemical (002258) have also shown upward movement, reflecting a broader trend in the sector [1] Group 2 - There is a notable influx of dark pool funds into these stocks, suggesting increased investor confidence and potential for further growth [1]

2025 年 07 月 03 日 晨会纪要 研究所： 证券分析师： 余春生 S0350513090001 yucs@ghzq.com.cn [Table_Title] 晨会纪要 ——2025 年第 111 期 观点精粹: 最新报告摘要 快递行业深度报告：末端降本三阶段，无人车打开新空间--行业 PPT 报告 一级市场项目进展顺利，二级市场收益承压--资产配置报告 草甘膦价格上涨，关注农药市场修复机会--行业动态研究 光伏设备行业深度报告：叠层钙钛矿：从 0 到 1，超越β——基于技术、设备及投资视角--行业 PPT 报告 证券研究报告 1、最新报告摘要 1.1、快递行业深度报告：末端降本三阶段，无人车打开新空间--行业 PPT 报 告 分析师：祝玉波 S0350523120005 联系人：史亚州 S0350124060026 一、末端降本背景：转运规模效应递减，末端降本空间大 1、快递价值链拆分：在行业价格下行背景下，成本控制直接决定盈利能力，且在转运成本降幅逐渐收窄的背 景下，末端成本管控成为网络竞争力关键。 2、降本看末端：以加盟制快递圆通速递为例，2024 年相比 2013 年，运输/操作/网点中转/面 ...

Group 1: Company Research - Fengyan Investment recently conducted research on Hongyang, noting that the price increase of core products in Q1 led to performance growth [1] - Major products such as Paraquat, Glyphosate, Chlorantraniliprole, and L-Glufosinate saw price increases, with Chlorantraniliprole's price recovering from 480,000 yuan/ton to 220,000 yuan/ton [1] - The company adheres to strict safety production regulations and environmental standards, with a biomass ethanol project in Yunnan having obtained approval for an annual production capacity of 100,000 tons [1] Group 2: Company Overview - Beijing Fengyan Investment Management Co., Ltd. was established on May 18, 2015, and has registered as a private securities investment fund manager [2] - As of the end of 2020, the company managed over 4 billion yuan across 14 funds, primarily funded by state-owned enterprises and financial institutions [2] - The company focuses on convertible bonds, exchangeable bonds, and other hybrid investment products, aiming to provide stable and high-cost performance investment returns [2] Group 3: Core Competencies - The company has extensive risk identification experience and strong project channel resources, having deepened cooperation with large state-owned enterprises and financial institutions [2] - A convertible bond scoring system has been established to effectively identify investment risks and values, with representative products achieving annualized returns exceeding 20% [2] - The core team has a background in various financial institutions, allowing for the creation of customized products and personalized services to quickly seize market investment opportunities [2]

Core Insights - The report maintains a "recommended" rating for the agricultural chemical industry, highlighting the recovery potential in the pesticide market due to rising glyphosate prices [1][8] - Glyphosate prices have shown a significant recovery, with the raw material price reaching 24,800 CNY per ton as of July 1, 2025, an increase of 1,800 CNY per ton since early April [6][8] Industry Performance - The basic chemical industry has outperformed the CSI 300 index over various time frames, with a 1-month performance of 5.0%, 3-month performance of 3.2%, and a 12-month performance of 16.4% compared to the CSI 300's 2.7%, 1.5%, and 13.6% respectively [4] Investment Highlights - The glyphosate industry is experiencing inventory depletion and demand recovery, leading to a price rebound from its bottom. As of June 27, 2025, glyphosate industry inventory was 40,000 tons, down 43,000 tons since early April [6] - The global largest glyphosate producer, Bayer, faces potential bankruptcy due to ongoing lawsuits related to its glyphosate product "Roundup," which could benefit domestic competitors in the glyphosate market [7] Company Focus - Key companies in the glyphosate sector include: - Jiangshan Chemical, with a production capacity of 70,000 tons/year [9] - Xingfa Group, the leading domestic glyphosate producer with a capacity of 230,000 tons/year [9] - Xin'an Chemical, with a capacity of 80,000 tons/year [10] - Yangnong Chemical, a major player with a capacity of 30,000 tons/year [10] - Guoxin Co., with a capacity of 20,000 tons/year [10] - Hebang Bio, with a capacity of 50,000 tons/year [10] - Lier Chemical, with a capacity of 18,500 tons/year [10] - Limin Co., with a capacity of 5,000 tons of glyphosate and 2,000 tons of refined glyphosate [10] Earnings Forecast - The report provides earnings per share (EPS) estimates for key companies, indicating potential growth in profitability: - Jiangshan Chemical: EPS of 1.10 CNY in 2025E [11] - Xingfa Group: EPS of 1.85 CNY in 2025E [11] - Yangnong Chemical: EPS of 3.44 CNY in 2025E [11] - Guoxin Co.: EPS of 1.12 CNY in 2025E [11] - Lier Chemical: EPS of 0.53 CNY in 2025E [11] - Limin Co.: EPS of 1.05 CNY in 2025E [11]